Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 9 (Table of Contents)
Published: 26 Sep-2013
DOI: 10.3833/pdr.v2013.i9.1980 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
The Italian pharmaceutical company Chiesi Farmaceutici has made a sweetened offer to acquire the 42% of Cornerstone Therapeutics that it does not already own for US$9...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS